{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477495412
| IUPAC_name = 4-amino-''N,N''-diisopropyl-''N''-methyl-4-oxo-3,3-diphenylbutan-1-aminium
| image = Isopropamide.png

<!--Clinical data-->
| tradename =  
| MedlinePlus = a694006
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = Rx-only
| legal_US_comment =  and Unscheduled
| legal_status = Unscheduled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 7492-32-2
| ATC_prefix = A03
| ATC_suffix = AB09
| PubChem = 3775
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01625
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3643
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8B9I31H724
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201232

<!--Chemical data-->
| C=23 | H=33 | N=2 | O=1 |charge=+
| molecular_weight = 353.52092 g/mol
| smiles = O=C(N)C(c1ccccc1)(c2ccccc2)CC[N+](C(C)C)(C(C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JTPUMZTWMWIVPA-UHFFFAOYSA-O
}}

'''Isopropamide''' ('''R5''') is a long-acting [[anticholinergic]] [[drug]]. It is used in the treatment of [[peptic ulcer]]s and other [[gastrointestinal disorder]]s involving hyperacidity (gastrointestinal [[acidosis]]) and hypermotility. Chemically, it contains a [[quaternary ammonium]] group. It is most often provided as an [[iodide]] salt, but is also available as a bromide or chloride salt. It was discovered at [[Janssen Pharmaceutica]] in 1954.

==References==
<references/>
* Seeherman R, Isopropamide iodide: a long-acting anticholinergic, Del Med J. 1957 Oct;29(10):265-9.
* Boss EG Jr, Buchanan GC, Effect of isopropamide iodide on basal gastric secretion in the human, Gastroenterology. 1957 Nov;33(5):730-6.

{{Drugs for functional gastrointestinal disorders}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Muscarinic antagonists]]
[[Category:Quaternary ammonium compounds]]
[[Category:Carboxamides]]
[[Category:Janssen Pharmaceutica]]
[[Category:Belgian inventions]]


{{gastrointestinal-drug-stub}}